Drug Trial Radar · NCT00403494
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
Last checked: Nov 20, 2026Latest source record: Jan 7, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
190
Actual
Start
Dec 2006
Primary completion
Nov 2008
Study completion Jan 2009
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Nov 23, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate whether sapropterin dihydrochloride is safe and effective in the treatment of intermittent claudication (IC) caused by peripheral arterial disease (PAD).
Conditions
- Intermittent Claudication
Interventions
PlaceboOther
Subjects receive matching oral Placebo twice daily for 24 weeks.
Sapropterin DihydrochlorideDrug
Subjects receive 400 mg oral sapropterin dihydrochloride twice daily for 24 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Peak Walking Time (PWT) From BaselineTime frame: Baseline and up to Week 24
- Number of Subjects With Adverse Events (AEs)Time frame: Up to 24-weeks
Locations
20 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Scottsdale, Arizona
Site not named
Sacramento, California
Site not named
San Diego, California
Site not named
Santa Ana, California
Site not named
Santa Rosa, California
Site not named
Clearwater, Florida
Site not named
Jacksonville, Florida
Site not named
Conyers, Georgia
Site not named
Indianapolis, Indiana
Site not named
Auburn, Maine
Site not named
Charlotte, North Carolina
Site not named
Portland, Oregon
Site not named
Knoxville, Tennessee
Site not named
Dallas, Texas
Site not named
San Antonio, Texas
Site not named
Norfolk, Virginia
Site not named
Richmond, Virginia
Site not named
Buenos Aires, Argentina
Site not named
Corrientes, Argentina
Site not named
Santa Fe, Argentina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.